
Streamex Corp.
96
Recent developments highlight Streamex’s progress in launching its gold-backed token GLDY, targeting institutional growth, and reporting Q3 2026 earnings. The company completed a $35 million public offering and repaid secured convertible debt, improving liquidity. Nasdaq listing compliance remains a concern.
- Streamex reported Q3 2026 earnings and discussed operational progress in its earnings call [N1].
- The company targeted institutional growth as its gold token GLDY generated first revenue, marking a milestone in commercialization [N2].
- Streamex completed a $35 million public offering in January 2026, strengthening liquidity [S2].
- The company issued a prepayment notice for previously announced convertible debenture financing and terminated a standby equity purchase agreement in early 2026 [S2].
- Nasdaq notified Streamex in October 2026 of non-compliance with minimum bid price requirements, initiating a compliance period through April 2027 [S2].
Streamex Corp. transitioned from a medical device technology company to a diversified technology platform centered on tokenized finance and real-world asset digitization through its acquisition of Streamex Exchange Corporation in 2025. The company operates an institutional-grade blockchain platform enabling issuance, trading, and infrastructure for digital tokens backed by tangible commodities, starting with gold. The legacy PURE EP™ Platform for cardiac electrophysiology remains part of the business but with limited recent commercial activity. Streamex Exchange launched the GLDY gold-backed token in 2026, beginning revenue generation. The company’s financials reflect early-stage commercialization with minimal revenue, significant net losses, and increased administrative expenses related to integration and stock-based compensation. Liquidity was strengthened by a public offering and debt repayment. The company faces risks related to stablecoin settlement dependencies and Nasdaq listing compliance.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Streamex Corp. operates a diversified technology platform focused on tokenized finance and real-world asset digitization, including a blockchain-based platform for tokenizing commodities such as gold. The company also maintains a legacy medical device business. Recent financials show minimal revenue and significant net losses driven by non-cash charges and stock-based compensation. Liquidity improved following a $35 million public offering and debt repayment. Risks include reliance on USDC stablecoin for settlement and Nasdaq listing compliance challenges.
Streamex’s development of a blockchain-based platform for tokenizing real-world assets, including gold, positions it to capitalize on emerging digital finance trends. The launch of GLDY and initial revenue generation demonstrate progress toward commercializing its tokenization platform. The company’s improved liquidity following a $35 million public offering and debt repayment supports ongoing development and strategic initiatives. Institutional growth targeting and partnerships could enhance adoption and platform maturity, potentially expanding revenue streams.
Streamex faces significant challenges including minimal historical revenue, substantial net losses driven by non-cash charges, and reliance on USDC stablecoin for transaction settlement, which carries risks of depegging and regulatory changes. The company’s Nasdaq listing is at risk due to non-compliance with minimum bid price requirements, potentially affecting liquidity and capital access. The early-stage nature of the tokenization platform and uncertainties around regulatory approvals, market adoption, and monetization pose execution risks. Losses on loaned assets to liquidity providers could adversely impact financial condition.
Streamex’s moat lies in its institutional-grade blockchain platform for compliant tokenization and exchange of real-world assets, a niche with regulatory and technological barriers to entry. The company’s early mover position in commodity-backed digital tokens, such as gold via GLDY, and its integration of legacy medical device technology provide diversified technology assets. However, the platform’s commercial success depends on regulatory developments, market adoption, and the ability to monetize tokenized products through fee-based services, which are subject to competitive and regulatory risks.
• Stablecoin Settlement Risk: The company’s reliance on USDC stablecoin for GLDY transactions exposes it to risks from stablecoin depegging, regulatory changes affecting Circle Internet Financial, and banking relationships underlying USDC reserves, which could impair token redemption and market confidence [S2].
• Liquidity Provider Loan Risk: Loaned USDC and GLDY tokens to a liquidity provider under an unsecured, interest-free agreement carry risk of partial or total loss if the provider fails, absent gross negligence or fraud, potentially impacting liquidity and financial condition [S2].
• Nasdaq Listing Compliance Risk: Streamex received a notice for non-compliance with Nasdaq’s minimum bid price requirement, with a compliance deadline in April 2027. Failure to regain compliance could lead to delisting, reducing stock liquidity and capital raising ability [S2].
• Early-Stage Commercialization Risk: The tokenization platform and legacy medical device business have generated minimal revenue historically, with significant net losses and increased expenses, reflecting early-stage commercialization and execution uncertainties [S1].
Business trends: Expansion of tokenized real-world asset platform with initial revenue from gold-backed token GLDY and institutional growth focus.
Execution milestones: Completion of $35 million public offering, repayment of secured debt, and ongoing platform development and commercialization efforts.
Key risks: Dependence on USDC stablecoin settlement, potential loss of liquidity provider assets, Nasdaq listing compliance challenges, and early-stage commercialization uncertainties.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Streamex Corp. operates a diversified technology platform focused on tokenized finance and digitization of real-world assets (RWAs), including gold and other physical commodities, through its Streamex Exchange platform [S1].
- The company also maintains a legacy medical device technology business centered on the PURE EP™ Platform for cardiac electrophysiology [S1].
- Streamex Exchange developed and operates a blockchain-based platform facilitating compliant tokenization and exchange of RWAs, with the gold-backed token GLDY launched in 2026 and generating initial revenue [S1][N2].
- The company’s revenue was minimal historically, with $0 in 2025 and $40 thousand in 2024, reflecting limited commercial activity in the PURE EP™ Platform and early-stage tokenization revenue [S1].
- Research and development expenses decreased significantly in 2025 compared to 2024, reflecting a shift in focus and resource allocation [S1].
- General and administrative expenses increased substantially in 2025 due to stock-based compensation and integration costs related to the Streamex Exchange acquisition [S1].
- The company reported a net loss of $462.8 million for 2025, driven by non-cash losses related to derivative liabilities and increased stock-based compensation [S1].
- As of September 30, 2026, Streamex had cash and cash equivalents of $5.48 million, short-term investments of $6.78 million, current assets of $25.49 million, and current liabilities of $3.45 million, resulting in a current ratio of 7.38 and a cash ratio of 3.55 [S2].
- The company completed a $35 million public offering in January 2026 and repaid its secured convertible debentures, improving liquidity [S1][S2].
- Streamex relies on USDC stablecoin as the primary settlement medium for GLDY transactions, exposing it to risks related to stablecoin depegging and regulatory changes affecting Circle Internet Financial, LLC [S2].
- The company has a loan agreement with a liquidity provider involving USDC and GLDY tokens, which carries risk of asset loss if the provider fails, absent gross negligence or fraud [S2].
- Streamex received a Nasdaq notice in October 2026 for non-compliance with the minimum bid price requirement, with a compliance period until April 5, 2027, to regain compliance or face potential delisting [S2].
- The company’s capital strategy includes maintaining liquidity to support operations, product development, and strategic initiatives, with potential future capital raises through equity, partnerships, grants, or debt [S1].
- Streamex’s business model visibility is enhanced by recent earnings call transcripts and news coverage detailing institutional growth targets and token revenue generation [N1][N2].
Generated 2026-11-15
- S1 | 2026-03-31 | 10-K
- S2 | 2026-11-12 | 10-Q
- N1 | 2026-11-13 | www.nasdaq.com | Streamex (STEX) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/streamex-stex-q3-2026-earnings-call-transcript
- N2 | 2026-10-16 | www.nasdaq.com | Streamex Targets Institutional Growth as Gold Token GLDY Generates First Revenue | https://www.nasdaq.com/articles/streamex-targets-institutional-growth-gold-token-gldy-generates-first-revenue
- N3 | 2026-08-17 | www.nasdaq.com | Biosig Technologies Q2 Earnings Call Highlights | https://www.nasdaq.com/articles/biosig-technologies-q2-earnings-call-highlights
- N4 | 2026-05-20 | www.nasdaq.com | Biosig Technologies Q1 Earnings Call Highlights | https://www.nasdaq.com/articles/biosig-technologies-q1-earnings-call-highlights
- N5 | 2026-05-20 | www.nasdaq.com | Stocks Settle Lower on Rising Bond Yields | https://www.nasdaq.com/articles/stocks-settle-lower-rising-bond-yields
- N6 | 2026-05-20 | www.nasdaq.com | Japanese Market Significantly Lower | https://www.nasdaq.com/articles/japanese-market-significantly-lower-0
- N7 | 2026-05-20 | www.nasdaq.com | Strong Gains, Full Exit — What H World's China Bet Could Mean Now | https://www.nasdaq.com/articles/strong-gains-full-exit-what-h-worlds-china-bet-could-mean-now
- N8 | 2026-05-20 | www.nasdaq.com | China Bourse May Hand Back Tuesday's Gains | https://www.nasdaq.com/articles/china-bourse-may-hand-back-tuesdays-gains
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


